INTELLECTUAL PROPERTY PROTECTION IN PHARMACOLOGY AND PHARMACEUTICS: RUSSIAN AND FOREIGN EXPERIENCE

Abstract

This article is dedicated to problematic experience, that the intellectual property rightholder may face in the sphere of pharmacology and pharmaceutics. It is displayed, what kind of measures are taken by the legal system, judicial system and rightholders in order to minimize the negative outcome caused by these problems. Intellectual property insurance mechanism is being analyzed as one of the effective methods of loss reduction for rightholders. Pharmaceutical and medical device manufacturers argue that the current patent system is crucial for stimulating research and development (R&D), leading to new products that improve medical care. The financial return on their investments that is afforded by patent protection, they claim, is an incentive toward innovation and reinvestment into further R&D. But this view has been challenged in recent years. Many commentators argue that patents are stifling biomedical research, for example by preventing researchers from accessing patented materials or methods they need for their studies. Patents have also been blamed for impeding medical care by raising prices of essential medicines, such as antiretroviral drugs, in poor countries. This debate examines whether and how patents are impeding health care and innovation. The question posed in the title of this debate seems to be a simple one, but there is a complex spectrum of answers depending on how one interprets the question. In this article, the author researches different interpretations and their corresponding answers.

Authors and Affiliations

M. G. Drobyshev

Keywords

Related Articles

DELIMITATION OF COPYRIGHT AND PATENT RIGHTS: GENERAL REMARKS

The article includes analysis of issues related to the problem of determining the boundaries of copyright and patent rights. The author points out that the protection of intellectual property rights (including copyright...

Conditions of accession in facto marriage

The article analyzes the formal and material conditions for marriage under operative family law. The conclusions about the necessity of application of law analogy to the conditions of entry into de facto marital relation...

STRUCTURAL FEATURES OF STATE-OFFICE LEGAL RELATIONSHIP OF THE STATE CIVIL EMPLOYEES AND THE ROLE OF LABOR LAW IN THEIR REGULATION

In the legal literature, investigating the legal relationship arising on civil service, various concepts of the characteristic of a concept of the state-office relationships of state-civil employee are offered. The main...

CONCEPT, CHARACTERISTICS AND PRINCIPLES OF IMPLEMENTATION OF THE INTELLIGENCE ACTIVITIES IN UKRAINE

The article is devoted to the study of the legislative definition of intelligence activities, as well as the regulation of the principles of its implementation in Ukraine. In the course of the study, there was a discrepa...

CONTRACTUAL CIVIL LEGAL RESPONSIBILITY IN SURROGACY RELATIONSHIPS

The article deals with the analysis of a civil contract of surrogacy and bases offensive contractual liability in the case of non-fulfillment or improper fulfillment by the parties of this agreement the terms and conditi...

Download PDF file
  • EP ID EP327526
  • DOI -
  • Views 85
  • Downloads 0

How To Cite

M. G. Drobyshev (2016). INTELLECTUAL PROPERTY PROTECTION IN PHARMACOLOGY AND PHARMACEUTICS: RUSSIAN AND FOREIGN EXPERIENCE. Вісник Одеського національного університету. Правознавство, 21(2), 122-127. https://europub.co.uk/articles/-A-327526